95 related articles for article (PubMed ID: 6866421)
1. Human tumor antigens inducing in vivo delayed hypersensitivity and in vitro mitogenic activity.
Tarro G; Pederzini A; Flaminio G; Maturo S
Oncology; 1983; 40(4):248-54. PubMed ID: 6866421
[TBL] [Abstract][Full Text] [Related]
2. Tumor liberated protein from lung cancer and perspectives for immunotherapy.
Tarro G
J Cell Physiol; 2009 Oct; 221(1):26-30. PubMed ID: 19507190
[TBL] [Abstract][Full Text] [Related]
3. In vivo delayed hypersensitivity reactions to partially purified human melanoma antigens.
Sutherland CM; Leong SP; Cooperband SR; Deckers PJ; Hornung MO; Krementz ET
J Surg Oncol; 1982 Aug; 20(4):221-6. PubMed ID: 7109625
[TBL] [Abstract][Full Text] [Related]
4. Depressed cell-mediated immunity in patients with primary intracranial tumors. Characterization of a humoral immunosuppressive factor.
Brooks WH; Netsky MG; Normansell DE; Horwitz DA
J Exp Med; 1972 Dec; 136(6):1631-47. PubMed ID: 4345108
[TBL] [Abstract][Full Text] [Related]
5. Effect of transfer factor on lymphocyte function in anergic patients.
Kirkpatrick CH; Rich RR; Smith TK
J Clin Invest; 1972 Nov; 51(11):2948-58. PubMed ID: 5080419
[TBL] [Abstract][Full Text] [Related]
6. Purification of soluble human melanoma-associated antigens.
Roth JA; Slocum HK; Pellegrino MA; Holmes EC; Reisfeld RA
Cancer Res; 1976 Jul; 36(7 PT 1):2360-4. PubMed ID: 776393
[TBL] [Abstract][Full Text] [Related]
7. Extraction of tumor-specific antigen from cells and plasma membranes of line-10 hepatoma.
Leonard EJ; Richardson AK; Hardy AS; Rapp HJ
J Natl Cancer Inst; 1975 Jul; 55(1):73-9. PubMed ID: 169367
[TBL] [Abstract][Full Text] [Related]
8. [Immunobiology of cancer].
Oettgen HF
Arch Klin Exp Ohren Nasen Kehlkopfheilkd; 1973; 205(1):21-36. PubMed ID: 4349192
[No Abstract] [Full Text] [Related]
9. Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.
Kamigaki T; Kaneko T; Naitoh K; Takahara M; Kondo T; Ibe H; Matsuda E; Maekawa R; Goto S
Anticancer Res; 2013 Jul; 33(7):2971-6. PubMed ID: 23780988
[TBL] [Abstract][Full Text] [Related]
10. Induction of delayed hypersensitivity reactions in cancer patients by cholesterol-hemisuccinate-treated autologous tumor cells.
Skornick Y; Dresdale AR; Sindelar WF
J Natl Cancer Inst; 1983 Mar; 70(3):465-7. PubMed ID: 6339776
[TBL] [Abstract][Full Text] [Related]
11. Relationship of skin reactive intestinal cancer antigen to the carcinoembryonic antigen of Gold and other antigens.
Herberman RB; Hollinshead AC; von Kleist S
Ann Immunol (Paris); 1973 Nov; 124(4):597-8. PubMed ID: 4134476
[No Abstract] [Full Text] [Related]
12. Active specific and active non-specific immunotherapy in patients with malignant melanoma.
Kokoschka EM; Cerni C; Micksche M
Oncology; 1977; 34(5):229-33. PubMed ID: 917456
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of nonspecific cell-mediated immunity in cancer patients. I. Frequent dissociation between the responses of skin tests to recall antigens and in vitro lymphocyte transformation.
Simmler MC; Rameau G; Chou MJ; Mathé G
Isr J Med Sci; 1976; 12(4-5):472-8. PubMed ID: 939695
[TBL] [Abstract][Full Text] [Related]
14. Studies of tumor-specific and herpesvirus nonvirion antigens.
Hollinshead A; Tarro G; Foster WA; Seigel LJ; Jaffurs W
Cancer Res; 1974 May; 34(5):1122-5. PubMed ID: 4842911
[No Abstract] [Full Text] [Related]
15. Delayed cutaneous hypersensitivity reactions to melanoma antigen.
Holmes EC; Roth JA; Morton DL
Surgery; 1975 Aug; 78(2):160-4. PubMed ID: 1154259
[TBL] [Abstract][Full Text] [Related]
16. Isolation of a soluble tumor-associated antigen from human melanoma.
Roth JA; Holmes EC; Reisfeld RA; Slocum HK; Morton DL
Cancer; 1976 Jan; 37(1):104-10. PubMed ID: 1247946
[TBL] [Abstract][Full Text] [Related]
17. Clinical observations on adoptive immunotherapy with vaccine-primed T-lymphocytes secondarily sensitized to tumor in vitro.
Chang AE; Yoshizawa H; Sakai K; Cameron MJ; Sondak VK; Shu S
Cancer Res; 1993 Mar; 53(5):1043-50. PubMed ID: 8439951
[TBL] [Abstract][Full Text] [Related]
18. The functions of the macrophage in malignant disease.
Alexander P
Annu Rev Med; 1976; 27():207-24. PubMed ID: 779596
[No Abstract] [Full Text] [Related]
19. The complexity of unique tumor-specific antigens.
Wortzel RD; Stauss HJ; Van Waes C; Schreiber H
Symp Fundam Cancer Res; 1986; 38():161-82. PubMed ID: 3749644
[No Abstract] [Full Text] [Related]
20. [The characterization of tumour-associated membrane-bound antigens and their implementation in the treatment of malignant melanoma (author's transl)].
Kokoschka EM
Wien Klin Wochenschr Suppl; 1979; 97():3-32. PubMed ID: 106559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
